Skip to main content

Critical Care Reviews Newsletter

Newsletter 525  |  January 3rd 2022

Register for the free weekly newsletter

CCR22 Registration Opens This Week

Welcome to the 525th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days. It's a short newsletter as it's been a quiet week for publications over the festive break. The highlight of this week's edition is a series of narrative reviews on the management of COVID-19 pneumonitis and acute respiratory failure. If you only have time to read one review article this week, try this one on an ecological definition of sepsis.

Critical Care Reviews Meeting 2022

Finally, registration opens this week for CCR22. We return to beautiful Titanic Belfast for our 10th anniversary meeting, which will be held in person Wednesday to Friday, June 15th to 17th. It's a relatively small meeting, so if you want to attend, you'll need to be quick to secure your place. Watch out for a specific email from us over the next few days to give you an early option to register for one of the best international critical care meetings available.

PLUS Trial Result Livestream

On Tuesday January 18th (19th on the other side of the International Date Line), Simon Finfer will present the results of the PLUS trial, comparing 0.9% saline with plasma-lyte 148 in 5000 critically ill patients. In addition, Naomi Hammond will present a systematic review and meta analysis comparing 0.9% saline with balanced crystalloid solutions. Deborah Cook will deliver an editorial, and the panel discussion will also include John Kellum, Gordon Guyatt, Tomoko Fujii and Jeff Drazen. This free livestream will be available on the CCR website, starting at 20:00 UTC+0.

Paper of the Day

We have re-instituted the Paper of the Day, which will have a clinical focus. By reading just one paper per day you'll be able to cover the wide spectrum of critical care conditions over the course of the year.

I hope you find this newsletter useful.


Until next week

Rob

 

Supported by

My Intensive Care Logo